Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thier is a reason it's undervalued and they know it and they know where their company is going.
Gums The Insider Buying Is Impressive...unbelievable really, looks like the whole board loaded up on shares in the spring. makes a person wonder what is to come. can't see them loading for no reason. they would know best, jmo
TBUFF $$$$ take a look on how much the people running the Company think about it. Great little Company here, if things run right $$$$$ TBUFF $$$$$$
http://www.secform4.com/insider-trading/1159019.htm
Still Bully
http://www.stockta.com/cgi-bin/analysis.pl?symb=TBUFF&cobrand=&mode=stock
GOOD READ a little info...
CAMBIA® which received approval from Health Canada in March 2012, is marketed by Tribute under an exclusive Canadian license from Nautilus Neurosciences, Inc. ("Nautilus"), a neurology focused specialty pharmaceutical company located in Bedminster, New Jersey. Nautilus, obtained exclusive U.S. and Canadian marketing rights for CAMBIA® from APR in 2005. The product is currently marketed in several European countries by Novartis Pharma AG, via a license from APR. Nautilus and APR have been granted patents that cover CAMBIA® through 2026. The last part was the best for a investor, patents until 2026. Some really big Pharma's lost their patents this year on migraine meds, big rev drop for them,
http://www.nautilusneurosciences.com/cambia/
This outfit seems to be a big holder, need more info on them. Could be the CFO
http://www.secform4.com/insider-trading/1536874.htm
TBUFF $$$$$$$$$ TBUFF is a holder due to the fact that so many shares are insider owned, and not on the market. Anybody got a float number? I would wager a small sum that they are close to being locked up.......
TBUFF Did a little digging, the Company is 82.43% insider owned. The majority of these share holders are board members, CEO, CFO, COO, etc. That's probably why volume is so lite, not that many shares to go around. On a NASDAQ sight I found out that most of these shares were bought in February 13 and March 13. http://www.nasdaq.com/symbol/tbuff/insider-trades Most of the buys were @.40 & @.56, these guys want to make money, all you have to do is hang on. Remember ALL BUYS NO SELLING
I added up 57,587,934 but that is more than the stated share count, so in the theory of Occam's razor, I am off somewhere between held and traded. This was also of interest.
http://www.otcmarkets.com/stock/TBUFF/company-info
NO SHORT INTEREST Aug 6th 2013 Market Value 35mil+
TBUFF looking better all the time! $$$$$ TBUFF $$$$$$
WINNER TBUFF !! IN* and AST* taking a huge beating! TBUFF is the real deal! TBUFF $$$ Everyone welcomed!
Would you look at that! Here it comes, Killer Whale and Shark attacks now! Go TBUFF $$$$
17k just thrown at TBUFF, that's big boy money, sharks are starting to circle... TBUFF $$$$
tbuff way undervalued as evidence of strong accumulation going on! multibagger
Thank you sir, see you when we get to Washington's $$$$ TBUFF
PERT on gapper bidding .71 little stock above
TBUFF I am showing bid @.71 ask @.74. You got any L2 info you could share, yes I know if I want to really trade, I should have a L2, but I don't, just using the old gut. TBUFF the Alchemist Stone, from metal to paper $$$$$$
lets get ready to rumble, $1.00 + this week! bring it on
Crazy .8's $$$ Would be great to see some volume and 8's today (just because). The more I look at Neovisc, the more I like it. Look at it's competitors like Synvisc. Great product in TBUFF lineup. Like Cambia as well. TBUFF $$$$$$
TBUFF vs other BIO Plays
One of the hardest things for any Bio to do is to get past stage 3 testing, then regulatory approval by the FDA to sell their products.
TBUFF http://www.tributepharma.com/ already has 8 on the market selling, and one or more in the pipeline. Now I cannot argue that companies like IN* are making huge gains just on the results of Phase 3 trials, and I like IN*. On the other hand SVF* is in the toilet before it even got anything out of the gate. Getting the product to market in BIO is the biggest hurdle for ANY company. TBUFF already has that in spades. So to put a twist on a old phrase, 8 in the hand is better than 1 in the bush... TBUFF $$$$
Oh revenue did I forget to mention revenue... $$$$$$$$
Looking real good it looks like accumulation not trading with to me suggest we going higher!
TBUFF looking good! Hope to get that rise going again later in the day. $$$$ TBUFF
little resistance, insiders are buying not selling and alot of others like myslef are investors not trading it as the potential is big. i look at $5.00 only a marketcan of $250mil which is cheap to its peers. lots of upside.
pecking away at .75's, will be interesting if this will break through that wall today
IGXT & TBUFF best OTC Biotech Plays
TBUFF Bully my lad, just bully!! TBUFF $$$$
http://www.stockta.com/cgi-bin/analysis.pl?symb=TBUFF&cobrand=&mode=stock
http://www.barchart.com/quotes/stocks/TBUFF
@@ at this! Some websites selling Neovisc TBUFF product, look at those prices $$$$$
http://www.medisave.ca/DrugMoreInfo2517.aspx
http://www.northdrugstore.com/buy-NeoVisc.html
http://www.candrug.com/DrugMoreInfo2517.aspx
TBUFF man what a find! $$$$$$
TBUFF $$$ Companies website must be getting a lot of traffic, seems to have been down for about a hour now. Lets see some good action out here today fellas. TBUFF $$$$$$
Would be great to close above the yearly high, really its only 7 months ago when TBUFF started to trade. Would love to see that $dollar bill$ this week, just don't know if retail can do it alone, need some Whales to swim into TBUFF waters.....$$$$$$$$$
Couldnt agree more tbuff is a great investment
TBUFF product testimonial on a migraine medicine in TBUFF line up, CAMBIA for migraines, and let me tell you with a wife that suffers with them, $10 to $50 a dose is well within the money people are willing to spend gladly that suffer these painful attacks. Entering full force in the U.S market. TBUFF easy play $ 1 dollar and beyond. Could be some VOLATILITY as bigger money tries to shake shares loose from retail holders. Short play flip could take a week or more, hold longer for bigger gains, but buying back in on dips will be harder. TBUFF $$$$
I have never been so happy to find a medicine. Cambia claims to relieve migraines within 15 minutes and at least for me, it does just that. I have suffered on and off with migraines for about 35 years and have not found anything that works like this.
The only downside with it is the cost. Even with an insurance RX card, it cost me $21 for 9 doses. My doctor initially gave me samples to try first. Knowing how good it worked, I didn't mind paying it.
Cambia works VERY quickly. You are actually supposed to take it on an empty stomach. This is printed in the patient instructions. My insurance didn't cover the cost of the prescription either. It is actually not $200 per packet, but $200 per prescription. There are nine packets with each prescription so that makes each dose about $22. I think that is worth it, considering my migraine was gone in 15 minutes!!!
Great Info, GG Gums. You should put these info on INO yahoo message board.
I read all your INFO on INO, GG Gums. You make me feel like buying more shares, which I may. Good job!
TBUFF products in use $$$$$
Tribute Pharmaceuticals Canada Inc.’s current portfolio of assets includes nine products: NeoVisc®, NeoVisc® Single Dose, Uracyst®, BladderChek®, Bezalip® SR, Soriatane®, Cambia®, Daraprim®, Collatamp G® and MycoVa™. Each of these products has received regulatory approval in Canada, with the exception of MycoVa.
Formed out of Stellar Pharm. January 2013. Just look at their product line up, sales, and future growth outlook. TBUFF $$$$
http://finance.yahoo.com/news/stellar-pharmaceuticals-announces-name-ticker-120000790.html
Best part of the read:
Recap of financial results for the first nine months of 2012 which include a 276% increase in revenues over 2011 levels
Expansion of national sales force to 24 reps with capacity to support additional products and revenues
Strong initial market response to CAMBIA® in Canada which may add significantly to future growth and revenues
Last 10Q Total revenues 3,422,180
Seems to be a little debt however....
No SHORT interest!https://www.interactivebrokers.com
They only have 4,000 shares available to short. There is no interest in shorting here. TBUFF $$$$$ Good gains here! A lot of BioTechs are going to take a big hit when this news gets fully aware of : Most Bio's trying to do Novel Stem Cell found that a high rate of the transplanted Stem Cells were dead and of no use after the transfer. TBUFF is a BIO but on the shelf prescription medication. Sure bet here, and cash income in the Mills, most Bio Techs run at a loss or low low numbers. TBUFF $$$$$$
Clinical trails for the use of one of Tribute Pharmaceuticals products, COLLATAMP G , I like this product $$$, already in use in other areas of surgery, will be testing the results using Collatamp in US knee replacements to prevent infections. All ready proven effective in all its other currant uses. So September 2014 will be $$$$, as I know the results will be good. This ticker could be a holder, and a good play on dips and rises.
http://clinicaltrials.gov/ct2/show/NCT01667874
TBUFF $$$$$
Useful links to this Companies products.
http://www.cambiarx.com/
http://www.healingwell.com/community/default.aspx?f=31&m=2101851
Showing it's Breached the Hull into the U.S. market more to come.
http://collatampg.ca/Allied-Health-Practitioners/Preventing-Surgical-Site-Infections-with-Collatamp-G
http://www.ncbi.nlm.nih.gov/pubmed/23092661
http://collatampg.ca/Patients-And-Caregivers/Preventing-Surgical-Site-Infections-with-Collatamp-G
Another solid product above. $$$
http://www.soriatane.com/index.html
http://en.wikipedia.org/wiki/Acitretin
Here is the home page for you to do some D&D and then buy in quick for nice gains. Company just started trading on the OTC in January 13'. Hovered in the .30 to .40 but now it has been noticed. Swift and heavy movement into the US markets with all of their own products. The Company revs are starting to show, and they are showing that along with other factors, this company is undervalued at the present time. TBUFF $$$
http://www.tributepharma.com/
Nice Close, $1.00+ next week.
Its on SBWIRE already. So investors/traders are looking , checking, and buying
Shake has started.
I SAY WE CLOSE AT HIGH JUST A PAUSE TO SEE IF SELLING, I THINK THOSE IN KNOW ITS A UNDERVALUED STOCK GOING TO $5.00 BUSKS MONEY WILL BE MADE! BAGGER TIME
My guess is we might see a little retail selling from here, but towards the EOD a big buyer should come in knowing the chatter over the weekend will propel this even higher. TBUFF $$$$
Retail trying to be shaken out, watch for a big buy on this dip. All is well carry on.. TBUFF $$$$$
Little East Coast Lunch dip, then back up late in the day strong, over .70 EOD. Sound good? TBUFF $$$$$$
MM's and Institutions must have smelled green in the water somehow. Large buys, beyond IHub scope. Good gainer TBUFF $$$$
Isn't that amazing! I'm buying while it's climbing. My cost basis is low anyway so i'm able to do that.
My sell limit order is in the dollars for 60 days. Locked up.
TBUFF $$$
I think chatter will now pick up on this board, these numbers and percentages get @@ noticed! TBUFF $$$$ Solid Company, Revs picking up $$$ TBUFF
Put High GTC Sell Order In Like $5 Guys ...
Q.: What can you do to prevent your shares holdings from being shorted?
A: Now what can the average personal investor do to stop their own shares being shorted, as believe me your own broker, if approached, WILL sell your own shares that they hold on your behalf as a nominee account.
There are two things you can do, the first is to certificate them but this is not obviously to everyone’s advantage but the alternative solution is simple. All you do is to phone your broker and put an order in saying that you wish to place your shares for sale at, for arguments sake, double today’s price. As they are 'on order' they cannot be lent out by your broker and in turn you are reducing the amount of 'free shares' out there that can be used for shorting purposes. And don't forget to move your limit order up when the price starts to recover, then, that way your shares can't be shorted - not much but helps :D.
Although an individual personal investor will not normally have enough shares to halt a concerted shorting attack, if a large number of holders did this it would reduce the overall amount of shares that they could get their hands on.
In my opinion well worth doing if not only for the knowledge that your own shares cannot and will not be used in a short attack against the very share that you own.
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
580
|
Created
|
10/21/08
|
Type
|
Free
|
Moderators |
Tribute Pharmaceuticals Canada Inc. (“Tribute”) is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US. The Company targets several therapeutic areas but has a particular interest in products for the treatment of pain, neurology, dermatology, cardiology, endocrinology and specialty care. Tribute also sells Uracyst® and NeoVisc® internationally through a number of strategic partnerships. Tribute currently markets NeoVisc® Single Dose, NeoVisc® Triple Dose, Uracyst®, Soriatane®, Bezalip® SR, Cambia®, Fiorinal®, Fiorinal® C, Visken® and Viskazide in Canada and has the US rights to Bezalip® SR and global rights to Uracyst® and NeoVisc® Additionally, Tribute has the exclusive Canadian rights to bilastine in Canada (not yet approved).
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |